XNAS · Healthcare · Medical Devices
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | Q1 2026 | -0.05 | -0.17 | -240.00% | $9.6M | ❌ Miss | +3.80% | +4.05% | — |
| 2026-03-26 | Q4 2025 | 0.17 | 0.03 | -82.35% | $13.1M | ❌ Miss | -1.86% | -10.34% | -0.80% |
| 2025-11-06 |
| Q3 2025 |
| 0.32 |
| 0.46 |
| +43.75% |
| $11.5M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-03-20 | Q4 2024 | — | -1.11 | — | $10.3M | — | +17.53% | +16.50% | -12.50% |
| 2024-11-07 | Q3 2024 | — | -6.49 | — | $9.4M | — | — | +0.00% | -5.25% |
| 2024-08-12 | Q2 2024 | — | 3.75 | — | $7.2M | — | +3.90% | +3.90% | +0.65% |
| 2024-03-21 | Q4 2023 | — | 11.25 | — | $7.0M | — | — | — | — |
| 2023-11-10 | Q3 2023 | — | -11.25 | — | $5.0M | — | -4.29% | -10.71% | -14.29% |
Showing last 8 quarters.